What is Acadia Pharmaceuticals's debt-to-assets?

Acadia Pharmaceuticals (ACAD) reported debt-to-assets of 0× in Q1 2026.

How has Acadia Pharmaceuticals's debt-to-assets changed year-over-year?

Acadia Pharmaceuticals's debt-to-assets decreased by 36.2% year-over-year, from 0× to 0×.

What is the long-term trend for Acadia Pharmaceuticals's debt-to-assets?

Over 5 years (2020 to 2025), Acadia Pharmaceuticals's debt-to-assets has grown at a -12.0% compound annual growth rate (CAGR), from 0.1× to 0×.

What does debt-to-assets mean?

Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.

Acadia Pharmaceuticals ACAD Debt-to-assets

Debt-to-assets at other companies

BiogenBIIB

0.2×0.0×

Neurocrine BiosciencesNBIX

0.1×0.0×

Catalyst PharmaceuticalCPRX

0×0.0×

PTC TherapeuticsPTCT

0.1×0.0×

BridgeBio PharmaBBIO

2.4×+2.4×

TG TherapeuticsTGTX

0.5×+0.1×

Other financials

Income statement

See full

Revenue$268.1M+9.7%

Gross profit$243.3M+8.6%

Operating income-$4.6M-124%

Net income$3.6M-80.8%

EPS (diluted)$0.02-81.8%

Balance sheet

See full

Cash & equivalents$282.2M+29.6%

Total debt$50.8M-9.3%

Total equity$1.2B+63.1%

Total assets$1.6B+41.8%

Cash flow

See full

Operating cash flow$34.0M+67.2%

CapEx$5.2M—

Free cash flow$28.8M+41.6%

Valuation

See full

Market cap$3.87B+37.0%

Profitability

See full

Gross margin91.5%-0.6pp

Operating margin7.4%-16.2pp

Net margin34.3%+11.3pp

FCF margin18.9%—

Returns & leverage

See full

Return on equity37.3%+0.1pp

Debt / equity0×0.0×

Current ratio3.6×+0.7×

Where this comes from

Calculated from Acadia Pharmaceuticals’s reported figures.

total debt/total assets=0×

Based on the most recent quarter.

The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Acadia Pharmaceuticals's debt-to-assets?: Acadia Pharmaceuticals (ACAD) reported debt-to-assets of 0× in Q1 2026.
How has Acadia Pharmaceuticals's debt-to-assets changed year-over-year?: Acadia Pharmaceuticals's debt-to-assets decreased by 36.2% year-over-year, from 0× to 0×.
What is the long-term trend for Acadia Pharmaceuticals's debt-to-assets?: Over 5 years (2020 to 2025), Acadia Pharmaceuticals's debt-to-assets has grown at a -12.0% compound annual growth rate (CAGR), from 0.1× to 0×.
What does debt-to-assets mean?: Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.